What are the Treatment Options for Respiratory Papillomatosis?
There is no cure for RRP. Treatment focuses on managing symptoms and keeping the airway open. Often, experts in head and neck surgery and voice disorders work together to create a personalized care plan.
Surgery
Surgery is the main treatment for RRP. The goal is to keep your child’s airway open and safe. Doctors do this by removing the growths as they appear.
Because growths can come back, many children need repeated procedures. Some children need surgery every few weeks. Others can go months between treatments. Care teams work to space out procedures as much as possible.
Doctors perform surgery by inserting small tools through the mouth, so there are no cuts on the outside of the body. They may use lasers or mechanical shavers (microdebriders) to destroy and remove the papillomas.
In severe cases, children with a blocked airway may need a tracheotomy (trach). During this procedure, care teams place a tube in the neck to help with breathing.
Additional Treatments
Doctors may recommend other treatments specific to each child. These options can slow the buildup of growths and extend the time between surgeries. They may be especially helpful for children with more severe disease or growths that return quickly.
One option is a medication called bevacizumab (Avastin). It works by blocking blood vessel growth factors that help papillomas grow. If the disease spreads to the trachea and lungs, care teams may give this treatment through an IV (intravenous) line.
Cidofovir is an antiviral medication that targets certain viruses, including HPV. Care teams may inject this medication directly into papillomas. Researchers are still studying its safety and effectiveness. It is not yet FDA-approved for RRP.
Some children with RRP also have gastroesophageal reflux (GER). Treating this condition may help reduce symptoms and slow virus activity.
Clinical trials offer access to other new treatment options. These include therapeutic vaccines that target active RRP infections.